On November 20, HHS released an Interim Final Rule with Comment Period (IFC) establishing a Most Favored Nation (MFN) Model for Medicare Part B drugs. The MFN Model will calculate the payment rate for included drugs based on a price that reflects the lowest per capita GDP-adjusted price among a group of OECD countries, with an additional flat payment based on the average payment for MFN Model drugs in 2019 adjusted quarterly for inflation.
AMCP Foundation recognizes Montrell Taylor, 2021 PharmD Candidate at Howard University College of Pharmacy, for his successful completion of the Genentech Evidence for Access Summer Internship Program.
AMCP Foundation congratulates three student pharmacists who recently completed two innovative programs on managed care pharmacy and nonprofit leadership, through the generous support of Pfizer, Inc.
AMCP Foundation proudly recognizes two student pharmacists who recently completed the Managed Care: Oncology Summer Internship program with the generous support of Pfizer, Inc.’s US Oncology Organized Customer Team.
AMCP Foundation recognizes two student pharmacists from the University of Southern California and University of Washington for the successful completion of the Specialized Summer Internship Program in Health Outcomes, sponsored by AbbVie, Inc.
Today, the Administration released a final rule, Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals, along with an interim final rule, Most Favored Nations (MFN) Model. In response, AMCP CEO Susan A. Cantrell, RPh, CAE, released the following statement.
Supreme Court Hears Oral Arguments in California v. Texas; AMCP Submits Comments on CMS Third COVID Interim Final Rule; AMCP Submits Comments on Medicare Coverage of Innovative Technology Proposed Rule; Pharmaceutical Supply and Payment Chain Coalition Releases Principles for Safe Access to COVID-19 Vaccine; HHS Partners with Pharmacies to Distribute COVID-19 Vaccine; CMS Releases Fourth COVID-19 Interim Final Rule with Comment Period (IFC-4); Trump Administration Releases Insurance Transparency Final Rule; FDA Releases Essential Medicines under ‘Buy American’ Executive Order; Election 2020: A Biden/Harris White House, Slim Democrat House Majority, and Senate Runoff.
